カナダの医療大麻大手のオーロラ・カンナビス社(NASDAQ:ACB)(TSX:ACB)は、2025会計年度第1四半期の財務・運営結果を報告し、前年度同期のCA$7473万に対し、CA$8344万($6...
ログインすると全部閲覧できます。
ログイン
Canadian medical marijuana giantAurora Cannabis Inc.(NASDAQ:ACB) (TSX:ACB) reported its financial and operational results Wednesday for thefirst quarter of fiscal 2025, revealingrevenue of CA$83.44 million ($60.72 million)compared to CA$74.73 million in the same period of fiscal 2024. Aurora attributes the 12% increase from the prior period to 13% growth in its global medical cannabis business and 16% growth in its plant propagation business, slightly offset by lower quarterly revenue in its consumer cannabis.
"This was a milestone quarter for Aurora, as we delivered strong net revenue growth, a substantial increase in adjusted EBITDA, and positive free cash flow," stated CEO...
カナダの医療大麻大手のオーロラ・カンナビス社(NASDAQ:ACB)(TSX:ACB)は、2025会計年度第1四半期の財務・運営結果を報告し、前年度同期のCA$7473万に対し、CA$8344万($6...
ブラウザの共有ボタンを使って、このページを友人と共有することができます。